<p>The recommended dose of Eribulin Mesylate is 1.4 mg/m2&nbsp;administered intravenously over 2 to 5 minutes on Days 1 and 8 of a 21-day cycle.<br />
<br />
The recommended dose of Eribulin Mesylate in patients with mild hepatic impairment (Child-Pugh A) is 1.1 mg/m2&nbsp;administered intravenously over 2 to 5 minutes on Days 1 and 8 of a 21-day cycle.<br />
<br />
The recommended dose of Eribulin Mesylate in patients with moderate hepatic impairment (Child-Pugh B) is 0.7 mg/m2&nbsp;administered intravenously over 2 to 5 minutes on Days 1 and 8 of a 21-day cycle.<br />
<br />
The recommended dose of Eribulin Mesylate in patients with moderate renal impairment (creatinine clearance of 30-50 mL/min) is 1.1 mg/m2&nbsp;administered intravenously over 2 to 5 minutes on Days 1 and 8 of a 21-day cycle.</p>

<p><a href="https://medex.com.bd/news/104/danger-of-taking-medication-without-doctors-advice" target="_blank"><em>* চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন</em></a>&#39;</p>